Skip to main content

Table 2 Fold change in gene expression of CRYβB2-overexpressing cells compared to control cells

From: A functional role for the cancer disparity-linked genes, CRYβB2 and CRYβB2P1, in the promotion of breast cancer

Gene symbol

Name

Fold

IL1RN

Interleukin 1 receptor antagonist

15.07

MMP13

Matrix metallopeptidase 13

12.38

IL1B

Interleukin 1 beta

9.45

TSHR

Thyroid-stimulating hormone receptor

5.92

IGF1

Insulin-like growth factor 1

4.93

CDH11

Cadherin 11, type 2, OB-cadherin

4.66

MMP3

Matrix metallopeptidase 3

4.41

FLT4

Fms-related tyrosine kinase 4

3.87

ITGB3

Integrin, beta 3

3.39

MMP9

Matrix metallopeptidase

3.39

VCAN

Versican

3.14

SOX10

Transcription factor SOX-10

2.61

SSTR2

Somatostatin receptor 2

2.53

CTSL

Cystatin F

2.48

RORB

RAR-related orphan receptor B

2.38

TMEM132A

Glucose-regulated protein, 78 kDa

2.14

CDH6

Cadherin 6, type 2, K-cadherin

− 10.62

FGFBP1

Fibroblast growth factor binding Prot. 1

− 7.78

WNT5B

Wnt family member 5B

− 7.32

CDH1

Cadherin 1, type 1, E-cadherin

− 6.33

COL3A1

Collagen, type III, alpha 1

− 5.63

DSP

Desmoplakin

− 5.09

CDKN2A

Cyclin-dependent kinase inhibitor 2A, p16

− 4.79

MAP1B

Microtubule-associated protein 1B

− 4.22

TGFB2

Transforming growth factor beta 2

− 3.88

MST1R

Macrophage-stimulating 1 receptor

− 3.14

DSC2

Desmocollin 2

− 2.93

WNT11

Wnt family member 11

− 2.75

MTSS1

Metastasis suppressor 1

− 2.68

KISS1R

KiSS-1 metastasis-suppressor receptor

− 2.28

ITGA7

Integrin, alpha 7

− 2.2

FGFR4

Fibroblast growth factor receptor 4

− 2.18